Article Details

Novartis rolls out encouraging phase 2 data in rare kidney diseases with little competition in sight

Retrieved on: 2021-06-07 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Novartis rolls out encouraging phase 2 data in rare kidney diseases with little competition in sight. View article details on hiswai:

Excerpt

The complement pathway is a part of the immune system that helps ... The U.S.-Swiss giant said iptacopan stabilized kidney function in patients with ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up